[Disclosure] Alteogen(196170) Designated as ‘Investment Warning Stock’; Takes Effect from September 23

Source Fact: Financial Supervisory Service DART / 2024-09-20

Disclosure Type: Designation of Investment Warning Stock

💡 3-Second Summary

Following a dramatic year-on-year surge of over 200% and highly concentrated buying activity, Alteogen has been formally designated as an ‘Investment Warning Stock’ effective September 23, suspending margin trading and exposing the stock to potential trading halts upon further sharp increases.

📊 1. [Summary of Core Disclosure Content and Major Figures]

• Target Stock: Alteogen Co., Ltd. Common Stock (Ticker: 196170)
• Effective Date of Designation: September 23, 2024
• Reason for Designation: All three regulatory conditions were fulfilled following a prior warning notice:
  1. The closing price on September 20, 2024, surged by more than 200% compared to the closing price from one year ago (September 20, 2023).
  2. The closing price on September 20, 2024, recorded the highest price among the closing prices of the past 15 consecutive trading days.
  3. As of September 20, 2024, the number of days where the buy involvement rate of the top 10 accounts met the regulatory threshold over the past 15 trading days was 4 days or more.
• Trading Suspension Condition: If the stock price advances by 40% or more within 2 trading days post-designation and stays higher than the closing price of the day prior to designation, trading may be temporarily suspended for a single instance.
• Criteria for Potential De-designation: Starting 10 trading days after designation, with October 08, 2024, set as the initial tentative judgment date (T), the status will be lifted on the following day if the stock does not meet any of the following parameters (otherwise delayed daily):
  1. The closing price on day T is 45% or higher than the closing price 5 trading days prior (T-5, tentatively September 27).
  2. The closing price on day T is 75% or higher than the closing price 15 trading days prior (T-15, tentatively September 10).
  3. The closing price on day T is the highest closing price within the past 15 consecutive trading days.
• Key Transaction Restrictions:
  • Entails a 100% upfront cash deposit requirement for new purchases.
  • Ban on margin trading (credit loans).
  • Excluded from substitute securities allocation.
  • Subject to potential ‘Investment Risk Stock’ upgrade upon sustained surges.

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing indicates a regulatory market intervention enforced by the Korea Exchange (KRX) to manage heightened speculative volatility stemming from rapid upward price trends. It functions purely as a structural trading restriction governed by quantitative price levels rather than an announcement identifying alterations in Alteogen’s pipeline, earnings fundamental, or corporate health.

From a market mechanics perspective, this regulatory classification may introduce a near-term liquidity cooling effect. Beginning September 23, the total restriction on utilizing credit leverage and the mandatory 100% cash requirement effectively restrict speculative capital inflows. Furthermore, market participants should factor in the operational risk of a temporary trading halt if a 40% gain occurs within the immediate two-day post-designation window. A balanced strategy requires monitoring price distributions relative to the upcoming de-designation evaluation on October 08, as compressed short-term liquidity typically amplifies statistical intraday volatility.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen’s powerful market rally has officially crossed the regulatory threshold, landing it firmly into the ‘Investment Warning Stock’ tier. A massive 200% year-on-year expansion combined with concentrated order flows from the top 10 accounts has prompted the KRX to apply the brakes. Starting September 23, retail investors lose the ability to deploy margin debt, and the 100% upfront cash requirement will inevitably choke off leveraged buying volumes. With the threat of a trading suspension looming if the stock climbs another 40% over the next two sessions, investors should prioritize risk mitigation over aggressive momentum trading until this regulatory phase cools down.

📢 Disclaimer and Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.